English
简体
繁體中文
日本語
General Contact
About
Company
Vision & Mission
What We Do
Leadership Team
About JSR Life Sciences
Scientific Advisors
Strategic Partners
Careers
News
CVMD
Menu Column 1
Cardiovascular Disease
NHP Models
Rodent Models
Diabetes
NHP Models
Rodent Models
Obesity
NHP Models
Rodent Models
Menu Column 2
NAFLD/NASH
NHP Models
MS-NASH (FATZO)
Liver Fibrosis
Rodent Models
Renal Disease
NHP Models
Rodent Models
Menu Column 3
Safety/Toxicology
Bioanalysis
Clinical Chemistry and Biomarkers
In Vivo
PK/PD
Non-GLP Toxicology
Safety Pharmacology
Biomarker Assay Services
Cytokine and Chemokine Profiling
Flow Cytometry
Genomics Services
Histology and Digital Pathology
Rare Cell Analysis
Oncology
Menu Column 1
In Vivo
Services
Breast Cancer Preclinical Models
Cell Line Derived Xenograft Models
Custom Tumor Model Development
Immuno-Oncology Models
MuScreen
Orthotopic and Bioluminescent Models
Patient-Derived Xenograft Models (HuPrime/HuKemia)
Prostate Cancer Preclinical Models
Radiation Therapy
Syngeneic Tumor Models
Menu Column 2
In Vitro
Services
Cell Based Screening
CrownSyn
Cell Line Panels
Flow Cytometry Platform
Immuno-Oncology
OmniScreen Cell Based Screening Service
Organoids
PDX-Derived Cell Lines
Organoids
Organoid and Immune
Cell Co-Culture
Ex Vivo
Services
3D Assays
Tumor Microarrays
Menu Column 3
Immuno-Oncology
CAR-T Cell Therapy Models
Humanized Models
Hematopoietic Stem Cell (HSC)-PDX
MiXeno
Human Target Knock-In Models
HuGEMM
HuCELL
Murine Immunity Models and Services
Tumor Homograft Models
Syngeneic Tumor Models
MuScreen
Translational Oncology
Biomarkers of Response (HuMark)
Mouse Clinical Trials (HuTrial)
Signatures of Response (HuSignature)
Menu Column 4
Biomarker Assay Services
Cytokine and Chemokine Profiling
Flow Cytometry
Genomics Services
Histology and Digital Pathology
Rare Cell Analysis
Bioinformatics
CrownSyn
Pharmacology and Bioanalytical Services
ADME & Physicochem
Bioanalysis Studies
In Vivo
PK/PD
NHP Immuno-Safety
Structural Biology
Target Validation
Oncology Databases
HuBase
OrganoidBase
MuBase
Onco
Express
XenoBase
Inflammation
Menu Column 1
In Vivo
Models
Inflammatory Bowel Disease (IBD)
Rheumatoid Arthritis (RA)
Menu Column 2
Biomarker Assay Services
Cytokine and Chemokine Profiling
Flow Cytometry
Genomics Services
Histology and Digital Pathology
Rare Cell Analysis
Models
Cell Line Derived Xenograft
HSC and PBMC Humanized
Human Target Knock-In ( HuGEMM
TM
)
Patient-Derived Xenograft ( HuPrime
TM
)
Syngeneic
Tumor Homograft ( MuPrime
TM
)
Resources
Blog
Databases
Onco
Express
HuBase
XenoBase
MuBase
Site Search 360
Call
Email
About
Company
Vision & Mission
What We Do
Leadership Team
Scientific Advisors
Strategic Partners
Careers
News
CVMD
Cardiovascular Disease
NHP Models
Rodent Models
Diabetes
NHP Models
Rodent Models
Obesity
NHP Models
Rodent Models
NAFLD/NASH
NHP Models
MS-NASH (FATZO)
Liver Fibrosis
Rodent Models
Renal Disease
NHP Models
Rodent Models
Safety/Toxicology
Bioanalysis
Clinical Chemistry and Biomarkers
In Vivo
PK/PD
Non-GLP Toxicology
Safety Pharmacology
Oncology
In Vivo
Services
Breast Cancer Preclinical Models
Cell Line Derived Xenograft Models
Custom Tumor Model Development
Immuno-Oncology Models
MuScreen
Orthotopic and Bioluminescent Models
Patient-Derived Xenograft Models
Prostate Cancer Preclinical Models
Radiation Therapy
Syngeneic Tumor Models
In Vitro
Services
Cell Based Screening
CrownSyn
Cell Line Panels
Flow Cytometry Platform
Immuno-Oncology
OmniScreen Cell Based Screening Service
Organoids
PDX Derived Cell Lines
Organoids
Organoid and Immune Cell Co-Culture
Ex Vivo
Services
3D Assays
Tumor Microarrays
Immuno-Oncology
CAR-T Cell Therapy Models
Cell Line Derived Xenografts Targeting CD19
PDX
Humanized Models
Hematopoietic stem cell (HSC)-PDX
HuGEMM
HuCELL
MiXeno
Murine Immunity Models and Services
Tumor Homograft Models
Syngeneic Tumor Models
MuScreen
Biomarker Services
Flow Cytometry Platform
Histology and Digital Pathology Platform
Pharmacology and Bioanalytical Services
ADME & Physiochem
Bioanalysis Studies
Flow Cytometry Platform
In Vivo
PK/PD
NHP Immuno-Safety
Structural Biology
Target Validation
Oncology Databases
HuBase
MuBase
Onco
Express
XenoBase
Oncology
Immuno-Oncology
CAR-T Cell Therapy Models
Cell Line Derived Xenografts Targeting CD19
PDX
Humanized Models
Hematopoietic stem cell (HSC)-PDX
HuGEMM
HuCELL
MiXeno
Murine Efficacy/PD Models
Tumor Homograft Models
Syngeneic Tumor Models
MuScreen
In Vitro
Services
Cell Based Screening
CrownSyn
Cell Line Panels
FACS Platform
Immuno-Oncology
OmniScreen Cell Based Screening Service
PDX Derived Cell Lines
Custom Cell Lines
In Vivo
Services
Breast Cancer Preclinical Models
Cell Line Derived Xenograft Models
Custom Tumor Model Development
Immuno-Oncology Models
MuScreen
Optical Imaging Platforms for Advanced Preclinical Modeling
Patient-Derived Xenograft Models
Prostate Cancer Preclinical Models
Radiation Therapy
Syngeneic Tumor Models
Ex Vivo
Services
3D Assays
Tumor Microarrays
Oncology Databases
HuBase
MuBase
Onco
Express
XenoBase
Pharmacology and Bioanalytical Services
ADME & Physiochem
Bioanalysis Studies
FACS Platform
In Vivo
PK/PD
Structural Biology
Target Validation
Inflammation
In Vivo
Models
Inflammatory Bowel Disease
Rheumatoid Arthritis (RA)
Biomarker Servicers
Flow Cytometry Platform
Histology and Digital Pathology Platform
Inflammation
Inflammatory Bowel Disease (IBD)
Rheumatoid Arthritis (RA)
Models
Cell Line Derived Xenograft
HSC and PBMC Humanized
Human Target Knock-In ( HuGEMM
TM
)
Patient-Derived Xenograft ( HuPrime
TM
)
Syngeneic
Tumor Homograft ( MuPrime
TM
)
Resources
Posters
Publications
Presentations
White Papers
On-Demand Webinars
Events
Quick Facts
FactSheets
Application Notes
Blog
Databases
Onco
Express
HuBase
XenoBase
MuBase
Contact
Unclear
Models
»
MuPrime™
»
Unclear
x
Unclear Tumor Homograft Models
MODEL
CANCER TYPE
ORIGINAL GEMM MUTATION
models per page
ALL
mXX6127
Unclear
VIEW MODEL
mXX6129
Unclear
VIEW MODEL
Create MuBase Account to View All Model Data
Already Registered?
Login
